Results for this period
Full year1 July 2025–30 June 2026Non-consolidated (standalone)Japanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Sales of major products declined mainly because the scale of the COVID-19 outbreak was substantially lower than in the previous fiscal year. As the impact of inventory adjustments in the commercial market during the fourth quarter of the previous fiscal year subsided, net sales in the fourth quarter under review exceeded those of the same quarter of the previous fiscal year. Government subsidies of ¥4,363 million were recognized as extraordinary income.
Not applicable.
| Item | Details |
|---|---|
| Fiscal Period Classification | Full year |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Non-consolidated (standalone) |
| Period Covered | 1 July 2025–30 June 2026 |
| Net Sales | ¥14,369 million (YoY -22.9%) |
| Operating profit | ¥4,200 million (YoY -49.2%) |
| Ordinary income | ¥3,952 million (YoY -51.9%) |
| Profit attributable to owners of the parent | ¥5,495 million (YoY -13.0%) |
| Net income per share | ¥52.28 |
| Operating Margin | 29.2％ |
| Equity ratio | End of the current fiscal period 43.5％ / End of previous period 47.7％ |
| Total assets | ¥44,620 million |
| Net assets | ¥19,420 million |
| Cash flows from operating activities | ¥-2,825 million |
| Cash flows from investing activities | ¥-6,175 million |
| Cash flows from financing activities | ¥3,297 million |
| Cash and cash equivalents at end of period | ¥3,563 million |
| Full-year earnings forecast | Net Sales ¥16,730 million (YoY +16.4%) / Operating profit ¥4,374 million (YoY +4.1%) / Ordinary income ¥4,026 million (YoY +1.9%) / Net income ¥2,965 million (YoY -46.0%) |
| Annual Dividend Forecast | 28 yen and sen → 29 yen and sen |
| Payout ratio | 53.6% (fiscal year ended June 2026), 104.3% (forecast for fiscal year ending June 2027) |
| Depreciation and amortization | ¥1,125,023 thousand |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of non-current assets ¥2,342 thousand, Government subsidies ¥4,363,603 thousand, Gain on reversal of subscription rights to shares ¥2 thousand / Extraordinary loss Loss on Disposal of Fixed Assets ¥43 thousand, Impairment loss on investment securities ¥31,458 thousand, Impairment Losses on Shares of Affiliates ¥391,404 thousand |
| Disclosure regarding the going concern assumption | Not applicable. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Material subsequent events | Not applicable. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Available (for institutional investors and analysts) |
| Issued Shares at Period-End | 106,691,686 shares |
| Treasury Shares at Period-End | 0 shares |
| Factors Behind Changes in Business Performance | Sales of major products declined mainly because the scale of the COVID-19 outbreak was substantially lower than in the previous fiscal year. As the impact of inventory adjustments in the commercial market during the fourth quarter of the previous fiscal year subsided, net sales in the fourth quarter under review exceeded those of the same quarter of the previous fiscal year. Government subsidies of ¥4,363 million were recognized as extraordinary income. |
Items this document does not state (8)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Although the influenza outbreak began earlier than usual and continued for an extended period, the scale of the COVID-19 outbreak was substantially lower than in the previous fiscal year, resulting in lower sales of major products. In addition, as the impact of inventory adjustments in the commercial market during the fourth quarter of the previous fiscal year subsided, net sales in the fourth quarter under review exceeded those of the same quarter of the previous fiscal year.